Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial
Davey Daniel (Corresponding Author), Vladimer Kuchava, Igor Bondarenko, Oleksandr Ivashchuk, Sreekanth Reddy, Jana Jaal, Iveta Kudaba, Lowell Hart, Amiran Matitashvili, Yili Pritchett, Shannon R. Morris, Jessica A. Sorrentino, Joyce M. Antal, Jerome Goldschmidt
Research output: Contribution to journal › Article › peer-review
64Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial'. Together they form a unique fingerprint.